Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma – First Initiators and Switchers

Simone Hashimoto(Emma Kinderziekenhuis), Elisabeth H. Bel(Amsterdam Neuroscience)
The Journal of Allergy and Clinical Immunology In Practice
April 26, 2022
Cited by 34


Related Papers

Exhaled Breath Profiling Enables Discrimination of Chronic Obstructive Pulmonary Disease and Asthma
|American Journal of Respiratory and Critical Care Medicine|2009|363
Factors Associated with Persistent Airflow Limitation in Severe Asthma
|American Journal of Respiratory and Critical Care Medicine|2001|360
“Refractory” Eosinophilic Airway Inflammation in Severe Asthma
|American Journal of Respiratory and Critical Care Medicine|2004|215
Severe adult-onset asthma: A distinct phenotype
|Journal of Allergy and Clinical Immunology|2013|213